ABioVaxys Technology Corp: BioVaxys Announces Results from T

VANCOUVER, BC, Dec. 16, 2022 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that possibly based on the selected study

Related Keywords

United States , Ohio , Canada , United Kingdom , Ohio State University , Vancouver , British Columbia , Frankfurt , Brandenburg , Germany , British , Canadian , Davin Shinedling , Kenneth Kovan , Biovaxys Technology Corp , Jba Inc , Biovaxys Or Company , Company Covid , Prnewswire Biovaxys Technology Corp , Vaxys Technology , Ohio State , Biovaxys President , Chief Operating Officer Kenneth , Biovaxys Technology , British Columbia Registered , Frankfurt Bourse , Abiovaxys , Technology , Orp , Nnounces , Results , Rom , Estate , University , Sarbecovirus , Animal , Study ,